Can population data guide surveillance strategies for second primary lung cancers?

Computed tomography (CT) screening for populations at high risk for lung cancer (LC) has demonstrated improvement in LC-speci c mortality and overall survival through earlier identification of potentially lethal LC (1). Similarly, CT surveillance following the radical treatment of rst primary lung cancer (FPLC) is crucial, as survivors remain at risk for both recurrence as well as second malignancies, particularly second primary lung cancer (SPLC).